Viewing Study NCT00688168


Ignite Creation Date: 2025-12-24 @ 5:50 PM
Ignite Modification Date: 2026-01-01 @ 10:55 AM
Study NCT ID: NCT00688168
Status: COMPLETED
Last Update Posted: 2019-05-29
First Post: 2008-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Inflammatory Cytokines in Symptom Production in Multiple Myeloma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Overview

Official Title: Identifying the Role of Inflammatory Cytokines in Symptom Production in Multiple Myeloma
Status: COMPLETED
Status Verified Date: 2019-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this research study is to learn about the pain and/or other symptoms that patients may experience either while you are being monitored by your doctor before a decision is made to start you on treatment for your MM, or during and after treatment for MM, and how these symptoms may affect therapy. A second goal is to learn how differences in genes may affect the symptom burden from cancer and cancer therapy.
Detailed Description: If you agree to take part in this study, you will complete 5 questionnaires during a regularly scheduled clinic visit. These questionnaires will measure pain and other symptoms, such as your mood and quality of life. You will also be asked to give a tissue sample by inserting a swab into your mouth and rubbing firmly against the inside of your cheek or underneath your lower or upper lip for about a minute at most. Completing the 5 questionnaires and the swab sample collection takes about 30 minutes in total.

This is an investigational study.

Up to 500 patients will take part in the cross-sectional phase of this study. All will be enrolled at MD Anderson.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: